Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Structural Biology

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/NSB0695-480PMID 7664111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

  1995cited by this paper
• Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance.

  1995cited by this paper
• Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.

  1994cited by this paper
• Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site.

  1994cited by this paper
• Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

  1994cited by this paper
• The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.

  1993cited by this paper
• Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus

  1993cited by this paper
• Structure-based inhibitors of HIV-1 protease.

  1993cited by this paper
• Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors.

  1993cited by this paper
• Crystal structures of HIV-1 protease-inhibitor complexes

  1993cited by this paper
• Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.

  1993cited by this paper
• The Feline Immunodeficiency Virus

  1993cited by this paper
• In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.

  1993cited by this paper
• Model peptides to study the effects of P2 and P3 substitutions in statine‐containing HIV proteinase inhibitors

  1993cited by this paper
• Crystal structure of a complex of HIV‐1 protease with a dihydroxyethylene‐containing inhibitor: Comparisons with molecular modeling

  1992cited by this paper
• Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.

  1992cited by this paper
• X-PLOR Version 3.1: A System for X-ray Crystallography and NMR

  1992cited by this paper
• Origin and General Nature of Retroviruses

  1992cited by this paper
• Comparative analysis of the sequences and structures of HIV‐1 and HIV‐2 proteases

  1991cited by this paper
• Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.

  1991cited by this paper
• Cloning, expression and kinetic characterization of the feline immunodeficiency virus proteinase.

  1991cited by this paper
• Biotinylation of transducin and G0 from bovine brain

  1991cited by this paper
• On the role of methionine residues in the sequence-independent recognition of nonpolar protein surfaces.

  1991cited by this paper
• Domain communication in the dynamical structure of human immunodeficiency virus 1 protease.

  1990cited by this paper
• Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

  1989cited by this paper
• Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

  1989cited by this paper
• Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution.

  1989cited by this paper
• Nucleotide sequence and genomic organization of feline immunodeficiency virus.

  1989cited by this paper
• The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

  1988cited by this paper
• Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures

  1987cited by this paper
• Stereochemically restrained refinement of macromolecular structures.

  1985cited by this paper
• [Structure and biosynthesis of proteins].

  1956cited by this paper

• The life cycle of feline immunodeficiency virus.

  2024cites this paper
• Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases

  2020cites this paper
• Comparison of a retroviral protease in monomeric and dimeric states.

  2019cites this paper
• Structure of RC1339/APRc from Rickettsia conorii, a retropepsin-like aspartic protease.

  2015influential citation
• Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells

  2015cites this paper
• Elucidation of the structure of retroviral proteases: a reminiscence

  2015cites this paper
• Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.

  2014cites this paper
• Chapter 54 – Feline Immunodeficiency Virus Retropepsin

  2013cites this paper
• Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein

  2013cites this paper
• Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus‐related virus protease

  2011cites this paper
• Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease.

  2011cites this paper
• The Molecular Biology of Feline Immunodeficiency Virus (FIV)

  2011cites this paper
• Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease

  2010cites this paper
• Comparative Studies on Retroviral Proteases: Substrate Specificity

  2010cites this paper
• Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

  2010cites this paper
• FIV vaccine development: a continuing challenge

  2008cites this paper
• Molecular mechanisms of FIV infection.

  2008cites this paper
• Specificity of retroviral proteinases based on substrates containing tyrosine and proline at the site of cleavage

  2008cites this paper
• Retroviral Proteases: A Potential Target for Development of Antiviral Agents

  2008cites this paper
• Comparative evaluation of the activity of antivirals towards feline immunodeficiency virus in different cell culture systems.

  2007cites this paper
• Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3

  2007cites this paper
• Kinetic and Crystallographic Studies of Drug-Resistant Mutants of HIV-1 Protease: Insights into the Drug Resistance Mechanisms

  2007cites this paper
• Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.

  2007influential citation
• FIV as a Model for HIV: An Overview

  2006cites this paper
• In vivo Models of HIV Disease and Control

  2006cites this paper
• Crystallographic Analysis and Kinetic Studies of HIV-1 Protease and Drug-Resistant Mutants

  2006cites this paper
• Altered Gag Polyprotein Cleavage Specificity of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Mutant Proteases as Demonstrated in a Cell-Based Expression System

  2006cites this paper
• Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design.

  2005cites this paper
• Studies of retroviral proteases

  2005cites this paper
• Inhibitor design by wrapping packing defects in HIV-1 proteins.

  2004cites this paper
• Feline Immunodeficiency Virus Retropepsin

  2004cites this paper
• Comparing Ligand Interactions with Multiple Receptors via Serial Docking

  2004cites this paper
• Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3

  2004cites this paper
• Characterization of Peptide Substrates and Viral Enzyme that Affect the Cleavage Site Specificity of the Human Spumaretrovirus Proteinase

  2004cites this paper
• Narrow Substrate Specificity and Sensitivity toward Ligand-binding Site Mutations of Human T-cell Leukemia Virus Type 1 Protease*

  2004cites this paper
• Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases.

  2003cites this paper
• HIV-1 protease: mechanism and drug discovery.

  2003cites this paper
• Proteolytic processing of foamy virus Gag and Pol proteins.

  2003cites this paper
• Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases

  2003cites this paper
• 9 Anatomy and pathology of HIV-1 peptidase

  2002cites this paper
• Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication.

  2002cites this paper
• Retroviral proteases

  2002cites this paper
• Anatomy and pathology of HIV-1 peptidase.

  2002cites this paper
• Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.

  2001cites this paper
• Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue.

  2001cites this paper
• Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3

  2001cites this paper
• Molecular Basis for the Relative Substrate Specificity of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Proteases

  2001cites this paper
• FIV Vector Systems

  2001cites this paper
• Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease

  2000influential citation
• 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.

  2000cites this paper
• Analysis of Human Immunodeficiency Virus Type 1 Containing HERV-K Protease

  2000cites this paper
• Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity

  2000cites this paper
• Structural and biochemical studies of retroviral proteases.

  2000cites this paper
• Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.

  2000cites this paper
• Structural studies of FIV and HIV‐1 proteases complexed with an efficient inhibitor of FIV protease

  2000cites this paper
• Methodology for protein–ligand binding studies: Application to a model for drug resistance, the HIV/FIV protease system

  1999cites this paper
• Structural biology of HIV.

  1999cites this paper
• Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.

  1999cites this paper
• Stabilization from Autoproteolysis and Kinetic Characterization of the Human T-cell Leukemia Virus Type 1 Proteinase*

  1999cites this paper
• Toward a universal inhibitor of retroviral proteases: Comparative analysis of the interactions of LP‐130 complexed with proteases from HIV‐1, FIV, and EIAV

  1998cites this paper
• Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.

  1998cites this paper
• Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.

  1998cites this paper
• A continuous fluorometric assay for the feline immunodeficiency virus protease.

  1997cites this paper
• Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite.

  1997cites this paper
• Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.

  1997cites this paper
• Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases

  1997cites this paper
• Structure of the D30N active site mutant of FIV proteinase complexed with a statine-based inhibitor

  1997cites this paper
• Structure of equine infectious anemia virus proteinase complexed with an inhibitor

  1996cites this paper
• C2-symmetrical tetrahydroxyazepanes as inhibitors of glycosidases and HIV/FIV proteases.

  1996cites this paper
• The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.

  1996cites this paper
• Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.

  1996cites this paper
• Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits

  1995cites this paper
• V-2 Nov 95

  year unknowncites this paper